Stay updated with breaking news from Real World Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Galderma announced today positive topline results from the phase III READY3 clinical trial investigating the use of RelabotulinumtoxinA for the treatment of glabellar lines frown lines and lateral canthal lines crows feet either alone singlearea or simultaneously.
Catherine C. Coombs, MD, presents data investigating venetoclax-based therapy after Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia.
In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patient’s baseline C-reactive protein (CRP) levels.
First presentation of results from primary analysis of Phase 2 TRANSCEND FL study evaluating second-line treatment with Breyanzi® in relapsed or refractory follicular lymphoma demonstrate its...
SHANGHAI, Oct. 31, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing